Brain, Vol. 123, No. 4, 665-676,
April 2000
© 2000 Oxford University Press
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK
Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 5BG, UK
Correspondence to:
B. K. MacDonald, Specialist Registrar in Neurology, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 5BG, UK
Over an 18-month period, all incident cases of neurological disorders were ascertained prospectively in an unselected urban population based in 13 general practices in the London area by a General Practice Linkage Scheme with the National Hospital for Neurology and Neurosurgery. In three of these practices, the lifetime prevalence of neurological disorders was also assessed. A population of 100 230 patients registered with participating general practices was followed prospectively for the onset of neurological disorders. Multiple methods of case finding were used to maintain accuracy. The age- and sex-adjusted incidence rates of neurological disorders were calculated. The lifetime prevalence of neurological disorders was surveyed in 27 658 of the patients. The age- and sex-adjusted incidence rates were calculated for major neurological conditions. [These are expressed as rates per 100 000 persons per annum, with 95% confidence intervals (CI) in parentheses]. The commonest of these were first cerebrovascular events, 205 (CI: 183, 230); shingles, 140 (CI: 104, 184); diabetic polyneuropathy, 54 (CI: 33, 83); compressive neuropathies, 49 (CI: 39, 61); epilepsy, 46 (CI: 36, 60); Parkinson's disease, 19 (CI: 12, 27); peripheral neuropathies, 15 (CI: 9, 23); CNS infections, 12 (CI: 5, 13); post-herpetic neuralgia, 11 (CI: 6, 17); and major neurological injuries, 10 (CI: 4, 11). Lifetime prevalence rates are also reported (expressed as rate per 1000 persons with 95% CI). The most prevalent conditions were: completed stroke, 9 (CI: 8, 11); transient ischaemic attacks, 5 (CI: 4, 6); active epilepsy, 4 (CI: 4, 5); congenital neurological deficit, 3 (CI: 3, 4); Parkinson's disease, 2 (CI: 1, 3); multiple sclerosis, 2 (CI: 2, 3); diabetic polyneuropathy, 2 (CI: 1, 3); compressive mononeuropathies, 2 (CI: 2, 3); and sub-arachnoid haemorrhage, 1 (CI: 0.8, 2). Overall, the onset of 625 neurological disorders was observed per 100 000 population annually. Six percent of the population had at some time had a neurological disorder. This is the first study of the incidence and lifetime prevalence of neurological disorders in recent times; we found that these disorders give rise to significant morbidity in the community.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Sathasivam, B. Lecky, R. Manohar, and A. Selvan Neuralgic amyotrophy J Bone Joint Surg Br, May 1, 2008; 90-B(5): 550 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ziegler, W. Rathmann, T. Dickhaus, C. Meisinger, A. Mielck, and for the KORA Study Group Prevalence of Polyneuropathy in Pre-Diabetes and Diabetes Is Associated With Abdominal Obesity and Macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3 Diabetes Care, March 1, 2008; 31(3): 464 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F D Dick, G De Palma, A Ahmadi, N W Scott, G J Prescott, J Bennett, S Semple, S Dick, C Counsell, P Mozzoni, et al. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study Occup. Environ. Med., October 1, 2007; 64(10): 666 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Pugdahl, A Fuglsang-Frederiksen, M de Carvalho, B Johnsen, P R W Fawcett, A Labarre-Vila, R Liguori, W A Nix, and I S Schofield Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 746 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.C. Sollom and I.I. Kneebone Treatment of depression in people who have multiple sclerosis Multiple Sclerosis, June 1, 2007; 13(5): 632 - 635. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri, and R. Zalutsky How common are the "common" neurologic disorders? Neurology, January 30, 2007; 68(5): 326 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bennetto, N. K Patel, and G. Fuller Trigeminal neuralgia and its management BMJ, January 27, 2007; 334(7586): 201 - 205. [Full Text] [PDF]
|
|
|
|
 |
|
 N. van Alfen The trouble with neuralgic amyotrophy Practical Neurology, October 1, 2006; 6(5): 298 - 307. [Full Text] [PDF]
|
|
|
|
|
|
J K Swanton, K Fernando, C M Dalton, K A Miszkiel, A J Thompson, G T Plant, and D H Miller Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison J. Neurol. Neurosurg. Psychiatry, September 1, 2006; 77(9): 1070 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A F J E Vrancken, S Kalmijn, E Buskens, H Franssen, M Vermeulen, J H J Wokke, and N C Notermans Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study. J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 397 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F D Dick Solvent neurotoxicity. Occup. Environ. Med., March 1, 2006; 63(3): 221 - 6, 179. [Full Text] [PDF]
|
|
|
|
 |
|
 N. van Alfen and B. G. M. van Engelen The clinical spectrum of neuralgic amyotrophy in 246 cases Brain, February 1, 2006; 129(2): 438 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N R Rosenberg and M Vermeulen Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy? J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1415 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Kemp, J. Kuntze, K. M. Attie, T. Maneatis, S. Butler, J. Frane, and B. Lippe Efficacy and Safety Results of Long-Term Growth Hormone Treatment of Idiopathic Short Stature J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5247 - 5253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Fuller How to get the most out of nerve conduction studies and electromyography J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(suppl_2): ii41 - ii46. [Full Text] [PDF]
|
|
|
|
|
|
D L Secker and R G Brown Cognitive behavioural therapy (CBT) for carers of patients with Parkinson's disease: a preliminary randomised controlled trial J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 491 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Corrao, A. Zambon, L. Bertu, E. Botteri, O. Leoni, and P. Contiero Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases J. Epidemiol. Community Health, December 1, 2004; 58(12): 1047 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B R Thanvi and T C N Lo Update on myasthenia gravis Postgrad. Med. J., December 1, 2004; 80(950): 690 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L J Edwards and C S Constantinescu A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic Multiple Sclerosis, October 1, 2004; 10(5): 575 - 581. [Abstract] [PDF]
|
|
|
|
 |
|
 S. T. Pendlebury, P. M. Rothwell, A. Algra, M.-J. Ariesen, G. Bakac, A. Czlonkowska, A. Dachenhausen, Y. Krespi, J. Korv, K. Krolikowski, et al. Underfunding of Stroke Research: A Europe-Wide Problem Stroke, October 1, 2004; 35(10): 2368 - 2371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Benito-Leon, F. Bermejo-Pareja, J. M. Morales-Gonzalez, J. Porta-Etessam, R. Trincado, S. Vega, and E. D. Louis Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain Neurology, March 9, 2004; 62(5): 734 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study Brain, March 1, 2004; 127(3): 550 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Sweeney, A Fryer, R Mountford, A Green, and I McIntosh Nail patella syndrome: a review of the phenotype aided by developmental biology J. Med. Genet., March 1, 2003; 40(3): 153 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J O Willoughby, S P Fitzgibbon, K J Pope, L Mackenzie, A V Medvedev, C R Clark, M P Davey, and R A Wilcox Persistent abnormality detected in the non-ictal electroencephalogram in primary generalised epilepsy J. Neurol. Neurosurg. Psychiatry, January 1, 2003; 74(1): 51 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C Heaney, B. K MacDonald, A. Everitt, S. Stevenson, G. S Leonardi, P. Wilkinson, and J. W Sander Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England BMJ, November 2, 2002; 325(7371): 1013 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gaist, U. Jeppesen, M. Andersen, L. A. Garcia Rodriguez, J. Hallas, and S. H. Sindrup Statins and risk of polyneuropathy: A case-control study Neurology, May 14, 2002; 58(9): 1333 - 1337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jirholt, A.-K. Lindqvist, J. Karlsson, A. Andersson, and R. Holmdahl Identification of susceptibility genes for experimental autoimmune encephalomyelitis that overcome the effect of protective alleles at the eae2 locus Int. Immunol., January 1, 2002; 14(1): 79 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 How Common Are Neurologic Diseases? Journal Watch Neurology, August 1, 2000; 2000(801): 16 - 16. [Full Text]
|
|
|
|
|
|
D. N. Robertson Enumerating neurology Brain, April 1, 2000; 123(4): 663 - 664. [Full Text] [PDF]
|
|